Outcomes4Me
Sucher für klinische Onkologie-Studien
Brustkrebs
Ort

Active, not recruiting • Phasen NA • Stufe 0, I, II, III, IV • Post-Menopausal • Non-interventional

Folgendes wird aus ClinicalTrials.gov importiert:

Abbreviated Breast MRI (AB-MRI) With Golden-angle Radial Compressed-sensing and Parallel Imaging (GRASP)

The purpose of this study is to use a magnetic resonance imaging (MRI) sequence called golden-angle radial compressed sensing and parallel imaging (GRASP) as a noninvasive and fast way to measure the wash-in contrast (dye) in the breast. MRI uses a strong magnetic field and radio waves to create images of structures in the body. The goal is to determine if benign and malignant breast lesions have different patterns of contrast wash in. This study will ask woman planning to undergo a clinical breast MRI with contrast (dye) as part of their standard care.

Breast Cancer

Studiendesign
Studientyp:

Observational

Geschätzte Einschreibung:

264 Teilnehmer

Aktueller Studienbeginn:

31. Juli 2018

Zulassungskriterien
Alter für die Studie berechtigt:

0 - 999

Geschlechter für die Studie berechtigt:

female


Arms and Intervention
  • Predictive Model

  • Breast Imagers

Einschlusskriterien
  • no contraindications to mri scanning (pacemaker, implanted metallic objects, severe obesity or other condition that leads to difficulty lying in the magnet)

  • able and willing to provide informed consent

Ausschlusskriterien
  • currently undergoing neoadjuvant chemotherapy for breast cancer treatment.

Trial Information at Site
Last Updated:
Studieninformationen
ClinicalTrial.gov ID:

Active, not recruiting

Estimated Enrollment:

264

Last Updated:

01/05/2024


Hauptermittler

Laura Heacock, MD


Studiensponsor

NYU Langone Health

Study Location (1)

NYU Langone Health

New York, New York, United States

Outcomes4Me

© 2024 Outcomes4Me Inc. All rights reserved.